CSIMarket
 

Healthcare Sector

Biotechnology & Pharmaceuticals Industry Profitability  


Profitability by Company within Biotechnology & Pharmaceuticals Industry


Company Quarter Gross Margin Net Margin Cash flow Margin ROE
Agilent Technologies inc 3 Q 54.73% 19.9% 22.55% 24.26%
Arca Biopharma Inc 3 Q - - - -36.75%
Advanced Biomedical Technologies Inc 2 Q 78.89% -110396.11% -108156.11% -
Acumen Pharmaceuticals Inc 3 Q - - - 14.86%
Achilles Therapeutics Plc 4 Q - - - -21.1%
Achieve Life Sciences Inc 3 Q - - - -240.36%
Arcellx Inc 1 Q - - - -
Acorda Therapeutics inc 3 Q 67.16% -41.34% -6.9% -95.51%
Adaptimmune Therapeutics Plc 3 Q - -565.01% -256.6% -116.62%
Adma Biologics Inc 3 Q 23.5% -36.26% -42.61% -58.25%
Edoc Acquisition Corp 4 Q - -586.26% 5.76% -
Adverum Biotechnologies Inc 3 Q - - - -59.42%
Aerie Pharmaceuticals Inc 3 Q 80.82% -74.25% 40.55% -
Agenus Inc 3 Q 98.65% -249.06% - -1159.04%
Applied Genetic Technologies Corporation 3 Q - - - -192.9%
Allied Healthcare Products inc 2 Q 7.39% -32.18% 76.74% -70.44%
Akoya Biosciences Inc 3 Q 57.86% -94.8% 26.28% -70.52%
Alector Inc 3 Q - -310.72% 80.57% -49.19%
Align Technology inc 3 Q 69.54% 8.17% 18.71% 14.01%
Aligos Therapeutics Inc 3 Q - -453.51% - -75.01%
Allogene Therapeutics Inc 3 Q - -169689.8% -44253.06% -37.74%
Allena Pharmaceuticals Inc. 2 Q - - - -287.46%
Allovir Inc 3 Q - - - -91.04%
Ambrx Biopharma Inc 4 Q - -916% - -35.95%
Amgen Inc 3 Q - - - 199.74%
Alpha Pro Tech Ltd 3 Q 32.73% 7.91% 1.19% 12.12%
Aptose Biosciences Inc 3 Q - - - -92.87%
Armata Pharmaceuticals Inc 3 Q - -643.8% -866.67% -70.29%
Arya Sciences Acquisition Corp Iv 3 Q - - - -
Aslan Pharmaceuticals Ltd 4 Q - - - -55.13%
Astrotech Corp 3 Q 15.79% -6657.89% -21526.32% -16.29%
Athira Pharma Inc 3 Q - - - -28.08%
Atara Biotherapeutics Inc 3 Q - -1885.87% -125.01% -104.2%
Aura Biosciences Inc 3 Q - - - -24.83%
Autolus Therapeutics Plc 4 Q - -17265.61% - -45.35%
Applied Uv Inc. 2 Q 22.07% -6.13% -74.09% -2.39%
Avanos Medical Inc 3 Q 54.48% 7.77% 5.2% 1.71%
Avrobio Inc 3 Q - - - -82.47%
Avantor Inc 3 Q 35.05% 9% 1.44% 14.51%
Anavex Life Sciences Corp 3 Q - - -183.91% -2.97%
Aspira Women s Health Inc 3 Q 55.79% -219.98% - -160.74%
Axcella Health Inc 3 Q - - - -567.25%
Acuity Brands Inc 4 Q 41.74% 7.51% 6.1% 18.95%
Ayala Pharmaceuticals Inc 3 Q 0% -11195.6% - -182.13%
Aziyo Biologics inc 3 Q 40.75% -79.99% -67.88% -1819.23%
Azz Inc 4 Q 19.58% -5.5% -2.96% -6.74%
Bioatla Inc 3 Q - - - -57.78%
Biocardia Inc 3 Q - -1441.98% -918.4% -172.74%
Brainstorm Cell Therapeutics inc 3 Q - - - -236.36%
Biocryst Pharmaceuticals Inc 3 Q 95.33% -56.08% -33.86% -
Black Diamond Therapeutics Inc 3 Q - - - -58.68%
Beam Therapeutics Inc 3 Q - -693.56% -690.6% -39.8%
Biogen Inc 3 Q 81.28% 45.24% 43.11% 20.44%
Bionovate Technologies Corp 3 Q - - - -
Bio rad Laboratories Inc 3 Q 54.9% -24.12% -11.55% -58.55%
Berkeley Lights Inc 3 Q 70.22% -100.79% -104.61% -47.12%
Bluebird Bio Inc 3 Q - -107774.65% - -194.95%
Biomerica Inc 4 Q 23.74% -109.73% -68.05% -66.11%
Bionano Genomics Inc 3 Q 25.05% -440.51% 13.95% -38.48%
Bionik Laboratories Corp 3 Q 61.2% -232.29% -191.49% -190.66%
Biontech Se 4 Q - - - 86.54%
Bruker Corporation 3 Q 52.48% 13.84% -15.18% 27.29%
Biondvax Pharmaceuticals Ltd 4 Q - - - -18.48%
Burzynski Research Institute Inc 4 Q - - - -
Cabaletta Bio Inc 3 Q - - - -53.52%
Candel Therapeutics Inc 3 Q - -28025.81% -30964.52% 32.54%
Trees Corporation 3 Q 35.9% -85.12% 30.88% -125.72%
Capstone Companies Inc 3 Q 23.51% -1059.13% -1291.54% -125.47%
Casi Pharmaceuticals inc 3 Q 58.42% -49.18% - -36.52%
Cannabis Global Inc. 2 Q 1.47% -59.89% -44.25% -66.53%
C4 Therapeutics Inc 3 Q - -473.17% -114.67% -30.11%
Chase Corporation 4 Q 34.88% 6.53% -252.3% 11.37%
Codiak Biosciences Inc 3 Q - -3693.1% - -37.62%
Cardio Diagnostics Holdings Inc 3 Q - - -14201.73% 0%
Cadre Holdings inc 3 Q 39.21% 4.43% 6.71% -
Cidara Therapeutics Inc 3 Q - - - -498.1%
Creative Medical Technology Holdings Inc 3 Q 70.91% -1786.07% -10717.45% -48.26%
Cen Biotech Inc 3 Q - -264.15% -94.3% -
Central Garden and Pet Co 4 Q 27.36% -1.41% -14.28% 10.15%
Conformis inc 3 Q 35.24% -110.29% -94.75% -78.14%
Compugen Ltd 4 Q 88.67% -570.05% 11.73% -32.06%
Cognition Therapeutics inc 3 Q - - - -28.61%
Coherus Biosciences inc 3 Q 22.43% -190.76% 24.92% -
Celldex Therapeutics inc 3 Q - -6580.84% -2412.29% -27.74%
Collplant Biotechnologies Ltd 4 Q 87.18% 1.52% 62.05% 0.53%
Cellectis S a 4 Q 45.26% -218.36% - -52.91%
Checkmate Pharmaceuticals Inc 1 Q - - - -83.92%
Compass Therapeutics Inc 3 Q - - - -31.38%
Cnbx Pharmaceuticals Inc 4 Q - - - -
Coeptis Therapeutics Holdings Inc 3 Q - - - -
Coherent Corp 3 Q 32.99% -2.88% 0% 2.4%
Caribou Biosciences Inc 3 Q - -806.75% -910.11% -10.38%
Cardiff Oncology inc 3 Q - -1555.54% -242.29% -27.78%
Curis Inc 3 Q - -470.58% -147.15% -82.91%
Crispr Therapeutics Ag 3 Q - -185690.43% -2917.02% -31.34%
Clarus Therapeutics Holdings Inc. 2 Q 71.36% -264.05% - -
Champions Oncology Inc 3 Q 47.88% -0.11% 19.38% 1.18%
Cytek Biosciences Inc 3 Q 66.36% 4.21% -20.68% -0.9%
Cel sci Corporation 3 Q - - - -89.93%
Cv Sciences Inc 3 Q 41.64% -27.49% 0.67% -580.24%
Ladrx Corporation 3 Q - - - -447.39%
Dbv Technologies S a 3 Q - -833.51% -1702.07% -44.34%
Ginkgo Bioworks Holdings Inc 3 Q 95.99% -1007.64% -113.44% -230.47%
Telesis Bio Inc 3 Q 54.82% -184.48% 39.46% -29.72%
Denali Therapeutics Inc 3 Q - -0.05% -69.5% 22.01%
Precision Biosciences Inc 3 Q - -325.22% - -121.11%
Dyadic International Inc 3 Q 31.46% -205.68% -311.2% -61.17%
Eargo Inc 3 Q 24.04% -640.2% -234.64% -973.79%
Editas Medicine inc 3 Q - -132680.95% - -41.33%
Educational Development Corporation 4 Q 63.52% 0% -0.59% -0.56%
Energy Focus Inc 3 Q -9.24% -150.91% -40.42% -246.71%
Eiger Biopharmaceuticals Inc 3 Q 69.41% -673.73% -255.07% -106.48%
Elevation Oncology inc 3 Q - - - -53.82%
Eloxx Pharmaceuticals Inc 3 Q - - - -863.78%
Enovis Corp 3 Q 56.23% -17.32% -10.59% 0.65%
Entera Bio Ltd 3 Q 25% - -335937.5% -
Enzon Pharmaceuticals inc 3 Q - - - -20.14%
Erytech Pharma S.a. 4 Q - - - -235.49%
Scientific Industries Inc 3 Q 50.53% -48.39% -19.98% -22.24%
Establishment Labs Holdings Inc 3 Q 68.09% -48.65% -67.75% -261.6%
Evaxion Biotech A 4 Q - - - -75.63%
Edwards Lifesciences Corporation 3 Q 80.76% 26.04% 3.7% 24.47%
Exscientia Plc 4 Q - - - 0%
Exelixis Inc 3 Q 96.28% 40.14% 9.49% 34.7%
Eyepoint Pharmaceuticals Inc 3 Q - -183.98% -67.64% -48.98%
Fate Therapeutics Inc 3 Q - -557.79% - -48.78%
4d Molecular Therapeutics Inc 3 Q - -5138.2% -1037.2% -36.94%
Fennec Pharmaceuticals Inc 3 Q - - - -214.78%
Homology Medicines Inc 3 Q - -4205.24% -16586.78% -1.94%
Forma Therapeutics Holdings Inc. 2 Q - - - -39.68%
Finch Therapeutics Group Inc 3 Q - -29254.35% -14044.2% -64.47%
Freeline Therapeutics Holdings Plc 4 Q - - - -116.56%
Fresh Tracks Therapeutics Inc 3 Q - -1238.27% -664.61% -133.55%
Fusion Pharmaceuticals Inc 3 Q - -14465.66% - -38.72%
Gilead Sciences Inc 3 Q 80.19% 25.36% -0.57% 16.09%
Monte Rosa Therapeutics Inc 3 Q - - - -12.47%
Gamida Cell Ltd 3 Q - - - 0%
Genocea Biosciences Inc 1 Q - -5917.78% -6300.37% -182.88%
Genfit S a 4 Q - 78.59% - 56.47%
Genenta Science S p a 4 Q - - - -14.23%
Green Planet Bioengineering Co Ltd 3 Q - - - -
Greenlight Biosciences Holdings Pbc 3 Q - -2203.12% - -368.54%
Gritstone Bio Inc 3 Q - -991.92% - -67%
Genethera Inc 4 Q - - - -
Halozyme Therapeutics Inc 3 Q 77.36% 29.49% 26.91% 95.77%
Harvard Bioscience Inc 3 Q 45.21% -12.65% 3.29% -8.91%
Health Discovery Corporation 3 Q - - - -
Cue Health Inc 3 Q 27.29% -95.28% -84.02% -14.14%
Hillevax Inc 3 Q - - - -
Heart Test Laboratories Inc 3 Q - - - -
Heska Corporation 3 Q 43.71% -0.71% 83.99% -3.97%
Htg Molecular Diagnostics Inc 3 Q 46.37% -361.04% -203.39% -310.66%
Humacyte Inc 3 Q - - - -7.01%
Hydrofarm Holdings Group Inc 3 Q 7.91% -31.74% -14.77% -51.15%
Immunitybio inc 3 Q - -94204.24% - -
Immucell Corp 1 Q 51.72% 8.56% 27.2% 2.69%
Icosavax Inc 3 Q - - - -10.02%
Idera Pharmaceuticals Inc 3 Q - -6324.49% - -48.24%
Idexx Laboratories Inc 3 Q 60.19% 21.5% -1.8% 118.38%
Ikena Oncology Inc 3 Q - -270.82% - -28.27%
Inhibikase Therapeutics Inc 3 Q - -61645.36% -362506.62% -59.24%
Illumina Inc 4 Q 64.3% -342.24% -31.03% -38.52%
Immunovant Inc 4 Q - - - -46.3%
In8bio Inc 3 Q - - - -42.68%
Inhibrx Inc. 2 Q - -5306.89% - -430.07%
Inogen Inc 3 Q 40.61% -9.02% -13.27% -13.94%
Mink Therapeutics Inc 3 Q - - - -38.71%
Inmune Bio Inc 3 Q - -7882.65% -3885.71% -43.02%
Iovance Biotherapeutics inc 3 Q - - - -76.45%
Innate Pharma Sa 4 Q - -213.78% - -49.15%
Century Therapeutics inc 3 Q - -1382.6% -64.61% -20.66%
Isoplexis Corporation 3 Q 50.79% -415.28% - -49.96%
Intuitive Surgical Inc 3 Q 67.55% 20.85% 0.18% 11.64%
Iteos Therapeutics Inc 3 Q - 5.09% -203.63% 42.61%
Invacare Corporation 3 Q 18.41% -20.16% 0.9% -49.37%
Invivyd Inc 3 Q - - - -20.27%
Jounce Therapeutics inc 3 Q - - - -0.01%
Jasper Therapeutics Inc 3 Q - - - -28.68%
Kaleido Biosciences Inc 4 Q - -17742.11% -29390.35% -227.69%
Kodiak Sciences Inc 3 Q - - - -62.79%
Kiromic Biopharma Inc 3 Q - - - -257.83%
Krystal Biotech Inc 3 Q - - - -23.14%
Kymera Therapeutics Inc 3 Q - -450.24% - -32.59%
Standard Biotools Inc 3 Q 45.06% -114.74% -55.22% -4329.61%
Lakeland Industries Inc 3 Q 43.34% 5.04% 40.48% -4.1%
Lifeloc Technologies Inc 3 Q 37.79% -4.28% -6.24% -8.99%
Lineage Cell Therapeutics Inc 3 Q 92.16% -204% -1536.49% -58.7%
Logicmark Inc 3 Q 61.94% -76.08% -65.98% -40.55%
Lucira Health Inc 3 Q -289.49% -368.89% -102.31% -89.63%
Atyr Pharma Inc 3 Q - - - -50.01%
Lixte Biotechnology Holdings Inc. 2 Q - - - -120.87%
La Jolla Pharmaceutical Company 2 Q 83.96% 23.31% 39.54% -
Lazuriton Nano Biotechnology u s a Inc 2 Q - - - -
Lantheus Holdings Inc 3 Q 61.61% 25.59% 35.64% 19.59%
Logicbio Therapeutics Inc 3 Q - -212.55% -296.87% -115.29%
U s Lighting Group Inc 3 Q -2.33% -128.49% -10.47% -
Lsi Industries Inc 3 Q 27.34% 4.93% 5.17% 12.46%
Microbot Medical Inc 3 Q - - - -116.84%
Mesoblast Ltd 2 Q - -894.33% - -15.71%
Meiragtx Holdings Plc 3 Q - -774.17% - -86.19%
Miromatrix Medical Inc 4 Q - - - -
Milestone Scientific Inc 3 Q 65.57% -89.61% -51.79% -57.8%
Molecular Partners Ag 4 Q - -653.94% - -59.45%
Moderna Inc 3 Q 67.3% 31% 4.64% 70.03%
Msa Safety Inc 3 Q 44.38% 11.76% 6.74% 8.19%
Mettler Toledo International Inc 3 Q 59.31% 22.38% 1.29% 1856.62%
Myriad Genetics Inc 3 Q 67.77% -22.44% 3.52% -8.18%
Mymd Pharmaceuticals Inc 3 Q - - - -83.89%
Mymetics Corporation 3 Q - -1034.62% 39.23% -
Myomo Inc 3 Q 66.45% -71.31% -70.96% -102.71%
Nanovation Microtech Inc 2 Q - - - -
Nanovibronix Inc 3 Q 82.47% -1029.9% -2032.99% -126.29%
Nautilus Biotechnology Inc 3 Q - - - -5.61%
Neurocrine Biosciences Inc 3 Q 98.43% 17.66% 12.61% 5.98%
Neogen Corporation 4 Q 48.92% -18.19% -3.09% -1.13%
Natural Health Trends Corp 3 Q 73.56% 0.4% -42.5% 0.64%
Neoleukin Therapeutics Inc 3 Q - - - -35.68%
Nanostring Technologies Inc 3 Q 53.55% -124.2% -30.32% -111.76%
Intellia Therapeutics Inc 3 Q - -853.53% -234.74% -47.79%
Nutriband Inc 3 Q 43.48% -174.03% -85.48% -38.44%
Livento Group Inc 3 Q 11.74% -27.57% -76.48% -401.3%
Novavax inc 3 Q 40.84% -22.95% -12.86% -
Nexien Biopharma Inc 3 Q - - - -
Ortho Clinical Diagnostics Holdings Plc 1 Q 50.11% 2.96% -5.72% 13.26%
Ocugen Inc 3 Q - - - -74.32%
Oncocyte Corporation 3 Q -2863.41% -23304.88% -31178.05% -90.73%
Orion Energy Systems Inc 3 Q 25.26% -13.27% 17.63% -8.24%
Olink Holding Ab publ 4 Q 61.29% -40.37% 0% -8.06%
Omega Therapeutics Inc 3 Q - -4335.97% -2393.78% -22.55%
Singular Genomics Systems Inc 3 Q - - - -4.78%
Organovo Holdings Inc 3 Q - -4312.99% - -41.86%
Opthea Limited 2 Q - -66087.32% - -33.52%
Orchard Therapeutics Plc 3 Q 71.53% -823.35% - -109.29%
Outlook Therapeutics Inc 3 Q - - - -232.57%
Oyster Point Pharma Inc 3 Q 75.89% -657.25% -646.34% -652.98%
Pacific Biosciences Of California Inc 3 Q 41.93% -238.22% - -42.23%
Palisade Bio Inc 3 Q - - - -114.49%
Passage Bio inc 3 Q - - - -67.18%
Pressure Biosciences Inc 3 Q 12.38% -3098.09% 75.89% -
Vaxcyte Inc 3 Q - - - -50.83%
Biomx Inc 3 Q - - - 89.58%
Peak Bio Inc 3 Q - - - -
Perkinelmer Inc 4 Q 57.18% 11.99% -58.97% 10.22%
Pulse biosciences inc 3 Q - - - -300.73%
Pluri Inc 3 Q - -7205.75% -1588.51% -104.15%
Protalix Biotherapeutics inc 3 Q 50.12% -25.15% -12.49% -
Pharmacyte Biotech Inc 3 Q - - - -6.49%
Predictive Oncology Inc 3 Q 76.27% -890.58% -626.49% -72.78%
Prime Medicine Inc 3 Q - - - -
Precipio inc 3 Q 19.68% -143.25% -105.15% -56.48%
Poseida Therapeutics Inc 3 Q - 60.54% -16.06% -18.27%
Polarityte Inc 3 Q - - - -85.41%
Mosaic Immunoengineering Inc 3 Q - - - -
Pactiv Evergreen Inc 3 Q 14.42% 10.94% 19.33% -9.99%
Quidelortho Corp 4 Q 51.99% 2.45% - 22.33%
Qiagen N v 4 Q 48.6% 17.17% 9.46% 16.55%
Quince Therapeutics Inc 3 Q - - - -60.28%
Quest Patent Research Corp 3 Q 46.4% 37.7% -55.34% -
Qrons Inc 3 Q - - - -
Quotient Limited 3 Q -138.45% -518.59% -333.43% -
Quanterix Corp 1 Q 60.09% -37.13% - -12.04%
Vicarious Surgical Inc 3 Q - - - 91.41%
Renovacor Inc 3 Q - - - -7.46%
Replimune Group Inc 3 Q - - - -35.72%
Reynolds Consumer Products Inc 3 Q 18.41% 4.96% -7.03% 14.43%
Repligen Corp 3 Q 56.9% 20.13% 3.64% 9.3%
Regenxbio Inc 3 Q 50.61% -284.72% -10.67% 11.12%
Relay Therapeutics Inc 3 Q - -24468.6% - -35.62%
Rapid Micro Biosystems Inc 3 Q -18.74% -0.15% -504.07% 4.38%
Rubius Therapeutics Inc 3 Q - - - -192.61%
Revolution Medicines Inc 3 Q - -2185.01% - -41.97%
Rewalk Robotics Ltd 3 Q 24.94% -616.25% -540.74% -21.55%
Recursion Pharmaceuticals Inc 3 Q -17.09% -459.31% 5.93% -53.04%
Sab Biotherapeutics Inc 3 Q - -197.12% -230.78% -22.59%
Sana Biotechnology Inc 3 Q - - - -45.49%
Seer Inc 3 Q 49.18% -606.32% - -18.8%
Seagen Inc 3 Q 78.81% -37.39% -1.26% -21.55%
Sangamo Therapeutics Inc 3 Q - -200.89% - -53.18%
Skyx Platforms Corp 3 Q 30.88% -66136.82% -129885.04% -
Solid Biosciences Inc 3 Q - - - -51.16%
Sanara Medtech Inc 3 Q 82.92% -10.82% -18.35% -27.49%
Senstar Technologies Ltd 4 Q 62.95% 36.75% -2.72% 35.89%
Senti Biosciences Inc 3 Q - -942.24% 0% -45.62%
Sophia Genetics Sa 4 Q 62.35% -182.14% - -26.75%
Spk Acquisition Corp 3 Q -55.59% -77.82% -8.14% -
Seqll Inc 3 Q - - - -32.44%
Sqz Biotechnologies Company 3 Q - 0% -617.67% -71.3%
Surgalign Holdings Inc 3 Q 72.81% -48.73% - -612.25%
Sorrento Therapeutics Inc 3 Q 58.14% -520.83% -203.45% -347.54%
Scholar Rock Holding Corp 3 Q - - - -54.3%
Surrozen Inc 3 Q - - - -75.92%
Steris Plc 3 Q 44.34% -26.26% -4.84% -0.15%
Sutro Biopharma Inc 3 Q - -77.5% 70.24% -53.85%
Surface Oncology Inc 3 Q - - - -52.58%
Springworks Therapeutics Inc. 2 Q - - - -38.19%
Talaris Therapeutics Inc 3 Q - - - -31.84%
Protara Therapeutics Inc 3 Q - - - -24.86%
Tarsus Pharmaceuticals Inc 3 Q - - - -34.24%
Tc Biopharm holdings Plc 4 Q - -686.12% 0% -
Tracon Pharmaceuticals inc 3 Q - - - -910.69%
Tcr2 Therapeutics Inc 3 Q - - - -49.52%
Tscan Therapeutics Inc 3 Q - -483.05% - -15.13%
Bio techne Corp 3 Q 66.6% 33.28% -2.71% 16.53%
Alpha Teknova Inc 3 Q 44.61% -210.19% -139.16% -21.75%
Talis Biomedical Corporation 3 Q -55.28% -3268.97% -2712.31% -59.9%
Tenaya Therapeutics Inc 3 Q - - - -44.57%
Trinity Biotech Plc 4 Q 40.96% 1% -0.18% -
Taysha Gene Therapies Inc 3 Q - - - -338.37%
Titan Pharmaceuticals inc 3 Q - -2776.84% -1971.58% -217.57%
10x Genomics Inc 3 Q 76.82% -31.98% -59.94% -14.21%
United Health Products Inc 3 Q 50.28% - - -
Valneva Se 4 Q 46.01% -21.09% 99.6% -43.04%
Avricore Health Inc 4 Q 24.85% -1390.9% - -77.75%
Vericel Corporation 3 Q 65.45% -17.06% 7.72% -10.41%
Vickers Vantage Corp I 3 Q - - - -
Vectivbio Holding Ag 4 Q - - - -75.01%
Vigil Neuroscience Inc 3 Q - - - -
Vir Biotechnology Inc 3 Q 94.06% 46.81% -144.9% 60.66%
Meridian Bioscience Inc. 2 Q 54.19% -10.83% 10.33% 12.28%
Volitionrx Limited 3 Q - -23668.66% -960.97% -350.47%
Vor Biopharma Inc 3 Q - - - -46.44%
Vaxart Inc 3 Q - - - -67.56%
Voyager Therapeutics Inc 3 Q - 42.9% 45.1% -21.97%
Windtree Therapeutics Inc 3 Q - - - -150.46%
X4 Pharmaceuticals Inc 3 Q - - - -200.38%
Acceleron Pharma inc 3 Q - -206.04% 0.16% -32.39%
Xtant Medical Holdings Inc 3 Q 54.6% -16.27% 5.23% -28.27%
Zimmer Biomet Holdings Inc 3 Q 70.76% 11.63% 9.52% 2.27%
Zivo Bioscience Inc 3 Q - - - -253.77%
Profitability
Biotechnology & Pharmaceuticals Industry
Gross margin contracted to 59.27 % in the 4. Quarter 2022 from 63.8 % in previous quarter, now Ranking #39 and ranking within sector #2.
Net margin for Biotechnology & Pharmaceuticals Industry is 20.21 % above industry average.

More on Biotechnology & Pharmaceuticals Industry Profitability

Biotechnology & Pharmaceuticals Industry achieved cash flow margin of 20.03 % and above average return on equity of 5.34 %

More on Biotechnology & Pharmaceuticals Industry Cash flow
More on Biotechnology & Pharmaceuticals Industry ROE







Cardiovascular Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Neuroscience Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Anti-Infective Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q

Respiratory Segment
Revenues Income
- - - -
Y/Y Q/Q Y/Y Q/Q




Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MSFT's Profile

Stock Price

MSFT's Financials

Business Description

Fundamentals

Charts & Quotes

MSFT's News

Suppliers

MSFT's Competitors

Customers & Markets

Economic Indicators

MSFT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071